At Coastal Vascular Institute we offer a variety of Clinical Trials to patients from across the states. We provide the most advanced treatment options available to everyone who enters our office. In the past, we have participated in multiple trials of products that are now currently on the market including the Boston Scientific Ranger trial, Bard Lutonix Drug-eluting Balloon, Cardiva – Vascade trial, Choice, and Sapphire. Don’t let your condition inhibit your life, learn more about the clinical trials we are offering today!
The providers at Coastal Vascular Institute are currently participating in 3 active clinical trials:
Life BTK is a clinical trial for Critical Limb Ischemia (CLI), in which blood vessels in the legs are blocked, drastically reducing blood flow to the feet. This is a study to test an investigational new device, called Esprit BTK, for the treatment of CLI. The device is made of a material that dissolves over time and will be eliminated from the body in about 3 years.
For more information please visit: The Life-BTK Study
LimFlow is a clinical trial for chronic limb-threatening ischemia (CLTI) in which blood vessels in the legs are severely diseased and there are no standard operations or procedures for treating the disease. The LimFlow system aims to improve blood flow by diverting a stream of oxygenated blood around the diseased arteries, through tibial veins and into the ischemic foot. The system consists of minimally invasive products that are designed to potentially enable perfusion of the ischemic foot and the possibility of wound healing.
For more information please visit: US Promise II Clinical Trial
Crest-2 is a clinical trial for carotid stenosis, a blockage or narrowing of the carotid arteries, which are the blood vessels that supply the brain with oxygenated blood. This condition can lead to stroke. Carotid stenosis requires treatment with medicine to lower the risk of stroke, medicines to optimize blood pressure, blood lipids, and as needed, medicines associated with the other risk factors of strokes. Carotid surgery, carotid stenting, and intensive medical management are all safe and established treatments for carotid stenosis. The goal of Crest-2 is to provide future guidance on which treatment strategy is the best. In the trial, each patient has intensive medical management of key risk factors for strokes and receives personalized dietary and lifestyle coaching to prevent strokes, as well as cognitive testing.
For more information please visit: Crest-2 Trial for Patients